L Gee
Overview
Explore the profile of L Gee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ball B, Woroszchuk E, Sukumaran A, West H, Afaq A, Carruthers-Lay D, et al.
BMC Microbiol
. 2021 Dec;
21(1):341.
PMID: 34903172
Background: Fungal infections impact over 25% of the global population. For the opportunistic fungal pathogen, Cryptococcus neoformans, infection leads to cryptococcosis. In the presence of the host, disease is enabled...
2.
Chen M, Vial M, Gee L, Davis R, St John J, Ekberg J
Sci Rep
. 2020 Jan;
10(1):951.
PMID: 31969642
Olfactory ensheathing cells (OECs) are crucial for promoting the regeneration of the primary olfactory nervous system that occurs throughout life. Transplantation of OECs has emerged as a promising therapy for...
3.
Parmar V, Gee L, Smith H, Pilitsis J
Clin Neurol Neurosurg
. 2014 Jun;
123:155-63.
PMID: 24956545
Refractory pain syndromes often have far reaching effects and are quite a challenge for primary care providers and specialists alike to treat. With the help of site-specific neuromodulation and appropriate...
4.
Schley M, Bayram A, Rukwied R, Dusch M, Konrad C, Benrath J, et al.
Eur J Pain
. 2012 May;
16(10):1414-25.
PMID: 22556099
Background: Neuropathy can lead not only to impaired function but also to sensory sensitization. We aimed to link reduced skin nerve fibre density in different levels to layer-specific functional impairment...
5.
Gee L, Abbott J, Conway S, Etherington C, Webb A
J Cyst Fibros
. 2004 Oct;
2(4):206-13.
PMID: 15463875
Background: Disease progression in cystic fibrosis (CF) is marked by deterioration across a number of physiological systems. In addition, there is evidence that females have a worse prognosis than males....
6.
Gee L, Abbott J, Conway S, Etherington C, Webb A
J Cyst Fibros
. 2004 Oct;
1(3):137-45.
PMID: 15463820
Background: Generic health-related quality of life measures are often applied to disease groups without assessment of their psychometric properties. The current work assesses the properties of the Short Form 36-item...
7.
Barnes R, Gee L, Taylor S, Briggs M, Harding S
Eye (Lond)
. 2004 Feb;
18(8):809-13.
PMID: 14963483
Aims: To report on the clinical efficacy of verteporfin photodynamic therapy (PDT) in the treatment of choroidal neovascularisation (CNV) in an NHS setting and to compare treatment rates and outcomes...
8.
Abbott J, Baumann U, Conway S, Etherington C, Gee L, von der Schulenburg J, et al.
Disabil Rehabil
. 2002 Jan;
23(18):837-44.
PMID: 11763280
Purpose: Quality of Life (QoL) is an important outcome measure in health care and pharmacological trials. The trend towards multinational clinical trials may be problematic because it is unclear as...
9.
Bluthenthal R, Kral A, Gee L, Lorvick J, Moore L, Seal K, et al.
J Acquir Immune Defic Syndr
. 2001 Nov;
28(3):264-9.
PMID: 11694834
Objectives: To determine trends in HIV infection and risk behaviors among street-recruited self-identified gay and bisexual male injection drug users (IDUs) in San Francisco. Methods: Trends in HIV infection and...
10.
Seal K, Kral A, Gee L, MOORE L, Bluthenthal R, Lorvick J, et al.
Am J Public Health
. 2001 Oct;
91(11):1842-6.
PMID: 11684613
Objectives: This study sought to determine prevalence of and risk factors for nonfatal recent overdose among street-recruited injection heroin users. Methods: From August 1998 through July 1999, 1427 heroin injectors...